Mersana Therapeutics, Inc. - COM (MRSN)

Historical Portfolio Holders from Q2 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
114M
Holdings value Q2 2024
$230M
Value change Q2 2024
-$24M
Grand Portfolio weight change Q2 2024
0%
Number of holders
119
Number of buys Q2 2024
58
Number of sells Q2 2024
-58
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 114M $230M -$24M $2.01 120
2024 Q1 117M $526M +$29.1M $4.48 124
2023 Q4 113M $262M +$13.7M $2.32 104
2023 Q3 114M $144M -$76.7M $1.27 126
2023 Q2 112M $370M +$12.9M $3.29 145
2023 Q1 106M $436M +$19M $4.11 154
2022 Q4 101M $593M +$39.1M $5.86 149
2022 Q3 85.1M $575M +$49.8M $6.76 144
2022 Q2 87.8M $405M +$42M $4.62 118
2022 Q1 80.8M $322M +$33.2M $3.99 125
2021 Q4 60.5M $376M -$4.57M $6.22 113
2021 Q3 66.7M $629M -$40.9M $9.43 107
2021 Q2 70.5M $957M -$10.4M $13.58 128
2021 Q1 67.3M $1.09B -$33.3M $16.18 128
2020 Q4 65.7M $1.75B +$31.2M $26.61 143
2020 Q3 66.9M $1.25B +$47.7M $18.62 129
2020 Q2 63.9M $1.49B +$669M $23.40 127
2020 Q1 40.1M $234M +$26.4M $5.83 81
2019 Q4 35.5M $203M -$6.01M $5.73 68
2019 Q3 35.7M $56.3M -$6.86M $1.58 69
2019 Q2 37.6M $152M +$5.95M $4.05 75
2019 Q1 36.9M $194M +$105M $5.26 64
2018 Q4 16.4M $66.7M -$9.13M $4.08 45
2018 Q3 19.8M $198M +$71.4K $10.00 45
2018 Q2 19.1M $342M +$7.92M $17.86 51
2018 Q1 18.7M $295M +$23.7M $15.77 56
2017 Q4 16.4M $270M -$3.74M $16.43 45
2017 Q3 16.6M $288M +$10.6M $17.29 40
2017 Q2 17M $236M +$236M $13.97 29